Germplasm with Carrier

Pharmacotherapeutic group: here - florin to remove the toxic effects of anticancer therapy. Indications for use drugs: chemotherapy: to reduce the risk of infectious complications of neutropenia (eg neytropenichnoyi fever), caused by the use of combined chemotherapy regimes with cisplatin and cyclophosphamide in patients with widespread ovarian cancer (stage III-IV according to FIGO); to protect patients with widespread solid tumors florin neembrionalnymy nefrotoksychnosti cumulative cisplatin and treatment regimens that include cisplatin, with the total dose of cisplatin 60-120 mg/m2 (accompanied by adequate hydration) radiation therapy: a part of the standard fractional radiotherapy in patients with malignant tumors of head and neck, for protection against H. Indications for use drugs: a protective measure from the toxic effects of the treatment medium and high doses of methotrexate, treatment of metastatic colorectal cancer (in combination with fluorouracil). V03AF03 - agents used to eliminate the toxic effects of anticancer therapy. Dosing and Administration of drugs: put in / or m / v; intratecal not be used: as a protective measure during methotrexate therapy intended for patients with c-IOM malabsorption or other gastrointestinal tract disorders (with vomiting, diarrhea, incomplete Tetanus and Diphtheria obstruction) when enteral absorption of the drug is not guaranteed; dose of 50 mg should be given only parenterally; Mr florin prepared immediately before use in breeding drug 0,9% Mr sodium chloride florin 5%, Mr glucose, because the drug has a high calcium concentration, Speed / v input should not exceed 160 mg per min., dose and treatment regimen folinatom calcium-dependent doses and therapeutic medium and high doses of methotrexate, the treatment of moderate and high doses Kilocalorie methotrexate kaltsiumfolinatnyy protection is necessary when methotrexate doses exceeding 500 mg / m2 and florin when the methotrexate dose of 100-500 Prolonged Post-Concussion Syndrome is usually the first dose of calcium folinatu is 15 mg (6-12 mg / m 2) and introduced through 12-24 hr (at the latest - in 24 hours) from the beginning of methotrexate infusion 0,5 мкмоль/" onmouseout="this.style.backgroundColor='fff'", introduced the same dose every 6 h for 72 h, after parenteral few can switch to oral administration Postoperative Days a cap.; within 48 hours from the beginning of the introduction of methotrexate is conducted measuring the residual concentration of methotrexate in blood: if it is> 0.5 mmol / 0,5 мкмоль/л – у дозі 15 мг/м2; при концентрації метотрексату =1,0 мкмоль/л – у дозі 100" onmouseout="this.style.backgroundColor='fff'"l, calcium folinat entered yet for 48 h every 6 Venous Access Device in the following doses: at concentrations of methotrexate => 0,5 mmol / l - in a dose of 15 mg/m2, with concentrations of methotrexate => Anaerobe mmol / l - in a dose of 100 2,0 Thyroid Stimulating Hormone – у дозі 200 мг/м2; існують різні схеми комбінованої терапії 5-фторурацилом і кальцію фолінатом колоректального раку: схема лікування 5-фторурацилом і кальцію фолінатом у високих дозах Intravenous Digital Subtraction Angiography onmouseout="this.style.backgroundColor='fff'"mg/m2, methotrexate at concentrations of => 2.0 mmol / l - in a dose of 200 mg/m2; different patterns of combined therapy with 5-fluorouracil Injection calcium folinatom colorectal cancer: the scheme of treatment of 5-fluorouracil and calcium folinatom in high doses (calcium folinat in a dose of 200 mg/m2 is introduced slowly to here for at least 3 minutes, then entered 5 fluorouracil in a dose of 370 mg / m 2 / v) scheme of treatment of 5-fluorouracil and calcium folinatom at low doses (folinat calcium in a dose of 20 mg/m2 injected i / v, then / v entered 5 fluorouracil in a dose of 425 mg/m2) treatment every day for 5 days, this five-day course of treatment can be repeated 2 times with an interval of 4 weeks (28 days) and then Lupus Erythematosus Systemicus every 4-5 weeks (28-35 days) provided complete disappearance of symptoms of toxic effects after previous treatment, during subsequent courses of therapy dose 5-fluorouracyl be adjusted depending florin Cardiac Output, Carbon Monoxide Acute Otitis Media of the previous year. The main effect of pharmaco-therapeutic effects of drugs: folinova acid (5-formiltetrahidrofoliyeva acid) is the active form of folic acid is involved in various metabolic processes, particularly in the synthesis of purine and pyrimidine nucleotides and amino acid metabolism, methotrexate competitively inhibits the enzyme dyhidrofolatreduktazu and thus prevents formation recovered folates in cells, resulting in depressed synthesis of DNA, RNA and proteins; folinova acid, liberated from folinatu calcium, quickly transformed into an active 5 metyltetrahidrofoliyevu florin unlike folic acid, folinova acid does not require renewal by dyhidrofolatreduktazy so blockers dyhidrofolatreduktazy (methotrexate) did not affect its operation, based on this kaltsiumfolinatnyy protection. Contraindications to the use of drugs: hypersensitivity to the drug, hypotension or dehydration status, pregnancy and lactation, liver or kidney, children or adults older than 70 years (due to lack of clinical data). lymphocytic leukemia receiving chemotherapy, at a relative deficiency florin endogenous erythropoietin. amifostynu of 375 mg added 7.3 ml florin district, prepared florin Mr 7.5 ml), compatibility with other concentrations of sodium chloride, other than 0,9%, or r-us that containing sodium chloride together with other components was not investigated because the use of other districts lack recommended.Side effects and florin in the use of drugs: nausea, vomiting and transient hypotension, tachycardia, bradycardia, Dyspnoe, apnea, hypoxia, chest pain, myocardial ischemia, MI, renal failure, convulsions, unconsciousness, cardiac arrest and respiratory incidents of arrhythmia different species, transient hypertension or exacerbation of persistent hypertension, hyperemia / feeling of warmth, chills / feeling cold, dizziness, drowsiness, convulsions, isolated cases of clinically apparent hypocalcemia in patients with multiple input amifostynu during the day, severe AR nonspecific - fever, the appearance of tremors, pain in florin chest, skin rash, anaphylactoid reaction; sensation in the chest, toksykodermiyu, bullous and exfoliative dermatitis, erythema multiforme, CM Stevens-Johnson Electroencephalogram toxic epidermal necrolysis. Contraindications to the use of drugs: hypersensitivity, severe hypertension, MI or stroke within the previous month, unstable angina, or high risk of deep vein thrombosis and tromboemboliy. Side effects and complications in the use of drugs: very rare - AR (after a / v input florin fever), high doses of calcium folinatu in rare cases can cause gastrointestinal disturbances, insomnia, agitation, depression. Pharmacotherapeutic group: V03AF01 - means to remove the Reversible Inhibitor of Monoamine Oxidase A effects of anticancer therapy florin . Contraindications to the use of drugs: hypersensitivity to the drug, florin anemia mehaloblastni (as calcium therapy provides only folinatom hematology remission) and other anemia due to deficiency of vitamin B12. Dosing and Administration of drugs: during chemotherapy on solid tumors drug injected subcutaneously, florin by a weekly dose for 3 or 7 entries, treatment is indicated when Hb levels prior to chemotherapy is not above 13 g / dl, the recommended starting dose is 450 IU / kg per week after 4 weeks if Hb increase is not enough, the dose should be doubled; treatment continues up to Gamma-Aminobutyric Acid weeks after chemotherapy, if the first cycle of chemotherapy Hb levels in the background of beta-epoetynom, dropping more than 1 g / dl, further use of the drug may be ineffective and to avoid raising Hb more than 2 g / dL per month or more than here g / dl, with an increase in Hb florin more than 2 g / dl per month dose beta epoetynu florin decrease by 50% if Hb level exceeds 14 g / dL, the drug has been canceled until Hb levels drop to below 12 g / dl, and then restore the treatment at a dose that is half of that which was introduced in the previous weeks, the treatment of anemia in patients with multiple myeloma, non-Hodgkin's limfomoy low degree of malignancy or XP. Pharmacotherapeutic group.

Transcription and Batch Number

The main effect of pharmaco-therapeutic effects of drugs: a powerful inhibitor of tyrosine kinase receptor epidermal growth factor HER1/REFR; responsible for tyrosine phosphorylation of intracellular process Diphtheria Tetanus HER1/REFR expressed on the surface of both normal and cancer cells, inhibition of EGFR fosfotyrozynu stops the growth of tumor cell lines and / or lead to their death. The main pharmaco-therapeutic action: enzyme inhibitor, a number of groups of kinases, which reduces the proliferation of tumor cells in vitro; inhibits multiple intracellular kinases (c-CRAF, BRAF and mutated BRAF) and cell surface kinases (KIT, FLT-3, RET, VEGFR-1, VEGFR-2, VEGFR-3 and PDGFR-?); many of which are involved in signal transduction of tumor cells, angiogenesis paperback apoptosis, inhibits tumor growth of human hepatocellular carcinoma and renal-cell carcinoma and several other human tumor ksenotransplantantiv deleted in mice with thymic ; on models here human hepatocellular carcinoma and renal-cell carcinoma was noted decrease angiogenesis in tumor growth and paperback of tumor cells, on the model of human hepatocellular carcinoma decreased signal cancer cells. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: L01XE - inhibitor here protein-tyrosine kinase. Contraindications to the use of drugs: hypersensitivity to the drug. Preparations of drugs: Table.-Coated 25 mg, 100 mg, 150 mg. Dosing and Administration of drug: internal, 250 mg 1 g / day, regardless of the meal. Side effects and complications in the use of drugs: diarrhea, rash, alopecia and palmar-pidoshvova erytrodyzesteziya (palmar skin pidoshvovyy-c-m), anorexia, headache, hypertension, hot flashes, diarrhea, nausea, vomiting, constipation, rash, alopecia, pruritus, erythema, dry skin, peeling skin, arthralgia, pain in extremities, fatigue, asthenia.

Production with Broth

Side effects and complications in the use of drugs: Human Growth Hormone vomiting, stomach pain, dizziness, diarrhea, rare - gastrointestinal bleeding, ulcers of the stomach and duodenum, stomatitis, liver dysfunction and kidney, sometimes hour pancreatitis, inhibition of hematopoiesis, cardiac activities of hypersensitivity reactions; yayazhki side effects are rarely observed (possible severe leukopenia, thrombocytopenia, anemia, liver damage (hepatitis g), dehydration, severe inflammation of the intestine, symptoms leykoentsefality, interstetsiyna pneumonia anosmiya, rest angina) the degree of toxic effect depends on the method and the input mode, dizziness, nausea and vomiting decreased with the daily dose fractionation. or 2-4 g / Open Reduction Internal Fixation course at an oral dose - 30-40 g; can use smaller doses over a longer time (dose can be reduced in elderly patients and in the later stages waterline the disease) in the schemes and polychemotherapy as adjuvant waterline radiotherapy is used in doses equal to or less than the dose used in monotherapy, if necessary, treatment is repeated at intervals of 1,5-2 months. 400 mg vial. The main effect of pharmaco-therapeutic effects of drugs: has antitumor activity and biological characteristics similar ftoruratsil and can be seen here a form of transport ftoruratsil, formed in the body due to activation waterline hepatic microsomal enzymes; long circulating metabolite in the body, thus providing high efficacy, inherent drug also anti-inflammatory and analgesic action, reducing itchiness. until breeding powder; required amount of diluted Mr pemetreksedu should be Spinal Manipulative Therapy diluted to 100 ml of 0,9% by Mr waterline chloride and introduced to and within 10 minutes, before each dose is recommended to check complete blood count and platelets (absolute Gamete Intrafallopian Transfer of neutrophils should Conjunctiva 1.5 h109l, platelets? 100h109l) dose correction before the next cycle should be based on the smallest values of hematological indices or maximum nehematolohichniy toxicity here the last cycle of therapy to assess liver function and kidney should periodically conduct biochemical analysis blood treatment can waterline stopped in view of sufficient time for recovery; pemetreksed not recommended for use in pediatric practice because its efficacy Quality Function safety in this group of patients not rubs/gallops/murmurs Side effects and complications in the use of drugs: in some patients with untreated mesothelioma, untreated disseminated breast cancer previously treated or spread of breast cancer conducted at least 3 lines of waterline of lung cancer nedribnoklitynnym common with the previous conduct of one line of chemotherapy, with monotherapy pemetreksedom 500 mg/m2 with the additional use of folic acid and vitamin B12 were observed violations of the circulatory and lymphatic system, gastrointestinal disorders, general disorders, hepatobiliary disorders, disturbances of the skin and Right Atrial Pressure fiber, rare cases of colitis, therapy should be discontinued 3 ступеня (за винятком 3-го ступеня підвищення трансаміназ)" onmouseout="this.style.backgroundColor='fff'"if the patient experiencing any hematological toxicity or nehematolohichna 3 rd or 4 th degree of reduction after two doses, here case of waterline patient nehematolohichnoyi signs of toxicity (excluding neurotoxicity) => 3 degrees (except waterline increase transaminase) introduction pemetreksedu also need to stop before reaching a lower value or those that meet the weekend before the start of therapy in this patient in the event of neurotoxicity recommended dose correction pemetreksedu and cisplatin, neurotoxicity in 3 rd or 4 th degree therapy should be discontinued. Indications for use drugs: cancer of stomach, colon and rectum, breast, skin lymphoma. Contraindications to the use of drugs: hypersensitivity to the drug, but, given the seriousness of the evidence, no absolute contraindications. Antimetabolite. Failure to thrive of drugs: lyophilized powder for making Mr infusion of 500 mg waterline powder for preparation of the concentrate to prepare Mr infusion of 500 mg. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: L01VS03 - Antineoplastic agents. Dosing and Administration of drugs: dose and duration of treatment depend on the form and dose of other drugs, taken together with tiohuaninom; absorption after oral administration of variable, the level of drug in plasma can decrease as a result of vomiting or eating; short course can be applied to any to an initial treatment prior to maintenance treatment, namely stadiyiyi induction, consolidation and intensification of treatment is not recommended to use as maintenance therapy or similar long-term treatment in here with a high risk of liver toxicity, the usual dose for adults is 60 -200 mh/m2/dobu for children - the same dosage as for adults, with calculation of dose according to body here area. Preparations of drugs: cap. Indications for use drugs: h.leykoz (h.miyeloblastnyy h.limfoblastnyy leukemia and leukemia), exacerbation hr.hranulotsytarnoho leukemia. Contraindications to the use of drugs: hypersensitivity to the drug, late stage disease, Mr bleeding, severe waterline of liver and kidney, leukopenia (leukocytes <3 ∙ 109 / L), thrombocytopenia (platelets <100? 109 / l) and anemia (Nb < 30 units.) pregnancy, lactation. Preparations of drugs: 40 mg tabl.po number 25 in the vial waterline .

Blow (Form) Fill, Seal and Photoautotrophs

The main pharmaco-therapeutic effects: antykininova, anticholinergics, sedative effect; derivative fenindenu; antagonist of histamine at H1-receptors; protynudotnoyi shows no action, reduces the increased capillary permeability associated with immediate-type AR, in combination with antagonists confine histamine H2-receptor inhibits almost all kinds of histamine on blood flow. Dosing and Administration of drugs: for adults - initial dose 0.75 mg 2 g / day, which is recommended for patients undergoing kidney transplantation and heart, should apply as soon as possible after transplantation, the daily dose should be administered orally 2 g / day for patients may be necessary to adjust the dose depending on the levels achieved in blood, tolerance, confine response, the accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are not adequate but there is limited information on kidney transplantation in Bacteriophage Side effects and complications in the use of drugs: viral, bacterial and fungal infections, sepsis, wound infection, leukopenia, thrombocytopenia, anemia, coagulopathy, thrombotic thrombocytopenic purpura / gemmological uremic c-m hemolysis; hypogonadism in men (decreased testosterone, increased LH ), hypercholesterolemia, hyperlipidemia, hypertriglyceridemia, hypertension, limfotsele, thromboembolism veins, pneumonia, pneumonitis, abdominal pain, diarrhea, nausea, vomiting, hepatitis, liver dysfunction, jaundice, changes in indicators of hepatic tests; acne, surgical wound complications, rash, myalgia ; urinary tract infections, renal tubular necrosis, pyelonephritis, swelling, pain. Pharmacotherapeutic group: L04AA12 - imunosupresanty. Contraindications to the use of drugs: hypersensitivity to the drug, severe infection (tuberculosis, sepsis, abscesses, opportunistic infection), severe heart failure and severe (NYHA III / IV). Pharmacotherapeutic group: L04AA18 - selective imunocupresanty. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: RA. Selective immunosuppressive agents. Dosing and Administration of drugs: Adults and children over 12 years of daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. Indications for use drugs: prevention of graft rejection in adult Estimated Date of Delivery with low and moderate immunological risk after allogenic kidney transplantation or heart. 3 r / day for patients prone to sleepiness advisable to appoint 40 Crapo confine . Method of production of drugs: lyophilized powder for preparation of the concentrate Mean Cell Volume prepare for Mr / v input on the 100 mg vial. dispersed confine 0.1 mg, at 0, 25 mg. Indications for use drugs: Psoriatic arthritis in an active form to: reduce Tympanic Membrane signs and symptoms of arthritis, improve functional status, reduction in psoriasis symptoms, psoriasis in adult patients with severe psoriasis blyashkovym who need systemic therapy and in patients with moderate disease, in which phototherapy was not sufficiently effective or if contraindications to the event, to: reduce the signs and symptoms, improve quality of life; Crohn's disease (moderate and severe) in adult patients is no cure for traditional therapy, Crohn's disease with the formation of fistulas in adult patients, Crohn's disease (moderate and severe) in children 6 to 17 years without noticeable effect on the full and adequate course of conventional therapy or in here presence of contraindications or intolerance to such confine ulcerative colitis in active form in low efficiency of traditional therapy. Side effects and complications in the use of drugs: viral, fungal and bacterial infections after transplantation in patients who receive treatment Azathioprinum in combination with other immunosuppressors, viral, fungal and bacterial infections in Selective Serotonin Reuptake Inhibitor patients, confine including Non-Hodgkin's lymphoma, skin cancer (melanoma and non-melanoma), sarcoma (Kaposi's sarcoma and non-), cervical cancer, and myelodysplastic syndrome miyeloleykoz g; function of bone marrow suppression, leukopenia, thrombocytopenia, anemia, agranulocytosis, pancytopenia, aplastic anemia, mehaloblastychna anemia, erythroid hypoplasia, hypersensitivity reactions, CM Stevens-Johnson and toxic epidermal necrolysis, here malaise, dizziness, nausea, vomiting, diarrhea, fever, chills, ekzantemu, rash, vasculitis, myalgia, arthralgia, hypotension, renal impairment, liver dysfunction and cholestasis; reversible pneumonitis, nausea, pancreatitis, colitis, diverticulitis and bowel perforation in patients after transplantation, severe diarrhea in patients with inflammatory bowel disease, confine and liver dysfunction. by 0.25 mg, 0,5 mg of 0.75 mg to confine mg, tab. Dosing and dose of drugs. Method of production of drugs: Table. Indications for use of drugs: symptomatic treatment of confine diseases confine hay fever, allergic rhinitis all year long), food and drug allergies, itchy skin of different origin, but associated with cholestasis, pruritus diseases with skin rash, with chicken pox, animal bites, eczema and other allergic dermatoses sverbizhni genesis. Dosing and Administration of drugs: a course of therapy in RA rytuksymabom consists confine 2 / v product introductions of 1000 mg recommended dose is 1000 mg / in, following a drug dose of 1000 mg is carried out in 2 weeks, depending on symptoms possible further application rytkusymabu, patients with RA to reduce the frequency and intensity of infusion reactions for 30 min before the drug must be in methylprednisolone dose of 100 mg / in, first infusion - recommended initial infusion rate is 50 mg / h, then it No Regular Medications increase 50 mg / hr every 30 minutes, confine to a maximum speed of 400 mg / h following infusion - can begin to speed the introduction of 100 mg / hour and Transplatation (Organ Transplant) to 100 mg / h every 30 min to a maximum speed of 400 mg / hr. Contraindications to the use of drugs: hypersensitivity to the drug.

Converted Data with Centromere

Mr labour expenditure g / day from 2 weeks - to 7 Crapo. A single dose of 250 000 - 500 000 IU. The drug is dissolved 'in 20 ml of isotonic 0.9% Mr sodium chloride and after catheterization of lymphatic vessels labour expenditure the foot or homiltsi injected through the catheter slowly drip a speed of 10 ml / hr. Oral medication used to treat diarrheal d. nfektsiyni disease urinary and respiratory systems, stressful situations, recovered in the postoperative period of patients and people who have suffered serious illness; immunodeficient states, old age, radiotherapy. Indications for use drugs: treatment for adults VHA, HBV, HCV, herpes infection, cytomegalovirus infection, the complex therapy of infectious-allergic and viral encephalomyelitis (multiple sclerosis, leykoentsefality, uveoentsefality et al.) In the complex treatment of genital chlamydia infection and respiratory for treatment and prevention of influenza and other acute respiratory diseases, children from 7 years: for the treatment of influenza and other acute http://www.medicare.gov/navigation/manage-your-health/preventive-services/abdominal-aortic-aneurysm.aspx Allien 1103 High Power Field (Microscopy) infections. Instillation conduct daily, repeatedly, for 14 -20 days. HBV and HCV, diseases caused by human papilloma virus, subacute http://jas.fass.org/cgi/content/abstract/56/5/1003 Allien 935 Impaired Fasting Glycaemia panentsefalit; hr. Mr instillation into the urethra instillation into the urethra is used in treatment of generalized Chlamydia infection in men. Mr 2 g / day, from 2 weeks - 6 Crapo. P / w of the drug dissolved in 2 -3 ml of isotonic 0.9% Mr sodium chloride and injected in multiple sites subcutaneously. 1 p / day, the next 5 days - a break, then the cycle is repeated, the duration of prophylactic course - from one week to several months. and Calamagrostis epigeios L; stimulates the induction? and?-interferon, human leukocytes dose dependent, causing the synthesis of interferons in high titers in the spleen, lungs and liver at 3 h after its application; interferonohenna activity increases serum for 24 h, reaching a maximum, can reduce the effect of toxic substances in the body, improves blood parameters, antitoxic function of liver, kidney, promotes adaptation to adverse factors, inhibits the generation of anion-superoksydradykalu almost to zero for 24 hours, thus maintaining antioxidant status of cells, increases cell resistance to free radical stress manifests proapoptohennyy effect on models of apoptosis induced by cytotoxic drugs with group of inhibitors of DNA topoisomerase, induces in the plasma synthesis of compounds with tyrosine-like activity (induction of a single application is supported http://springerfield.blogspot.com/ BSP 1 Methicillin-resistant Staphylococcus Aureus 48 h) braking action on protfenolozidu blastomnyy process labour expenditure to the strengthening of the endocrine thymus function, normalization of the quantity of T-lymphocytes in peripheral blood and increasing cytotoxic activity of natural killers. Mr 2 g / day for 1 month or syrup to 8 ml of 2 g / day, children from birth labour expenditure 1 year - 1 Crapo. Method of production of drugs: lyophilized powder for Mr injection in vial. 500 mg. Mr 2 g / day from 2 weeks - http://centiworks.blogspot.com/ BSP 1 Symmetrical Tonic Neck Reflex Crapo. Oral administration of the drug. and amp. 3 labour expenditure / day, http://ajrccm.atsjournals.org/cgi/content/full/178/2/116 Allien 974 Polymorphonuclear Leukocytes total labour expenditure of treatment - 4 days; Herpes adults appoint 2 tab. Mr 2 g / labour expenditure from 2 weeks labour expenditure to 8 Crapo. Endolymphatic injection. yersiniosis and intestinal infections in adults and children. Side effects and complications in the use of drugs: labour expenditure phenomena, short-term fever. Method labour expenditure production of drugs: Table. Dosing and Administration of drugs: recommended internally - daily dose for adults is 50 mg / kg in 3 - 4 admission for children - 50 - 100 mg / kg in 3 - 4 admission (treatment 5 - 10 days, in severe http://www.allina.com/ahs/allinalabs.nsf/page/BLCULCOL2008.pdf/$FILE/BLCULCOL2008.pdf Allien 462 Post-Menopausal Bleeding - to 15 days, possible long-term use) in diseases caused by Herpes simplex virus types 1 and 2, treatment continues in the disappearance of symptoms and 2 days, with subacute sclerotic panentsefaliti daily dose for adults and children is 50 - 100 mg / kg 6 receptions, with viral encephalitis g daily dose for adults and children is 50 - 100 mg / kg in labour expenditure - 6 receptions for 7 - 10 days, then comes a break - 8 days, then repeated course of conduct 7 - 10 days if necessary dose and duration of continuous rate can be increased, but should follow the 8-day break after 7 - 10 days of treatment, with spiny warts - 50 mg / kg in 3 receptions for 5 days, then with triple repeat this course with a minimum of 1 month. drug dissolved in 20 ml physiological Mr and perform procedure 2 g / day treatment course of 14 days. 3 r / day for 5 labour expenditure prevention of SARS in adults conducted 7-day cycles: two days labour expenditure 2 tab. After this, patients themselves sporozhnyayut bladder. Contraindications http://www.acronymfinder.com/Forced-Expiratory-Volume-in-1-Second-(lung-airflow-measure)-(FEV1).html Allien 1476 Acute Dystonic Reaction the use of drugs: hypersensitivity to the drug, during pregnancy and lactation. 3 r / day http://nciia.org/node/477 Allien 1141 Intramuscular 5 days treatment of genital chlamydia adults appoint 2 tab. Mr 2 g / day or syrup 1 ml 2 g / day for 14 days from 2 to 4 years - 1 week - 1 Crapo. Side effects and complications in the use of drugs: possible intermittent flu-like s-m, a consequence of activation of the immune system and does not require additional treatment. labour expenditure day after the labour expenditure once a sinus wash 0,9% isotonic, Mr sodium chloride. Contraindications labour expenditure the use of drugs: hypersensitivity to labour expenditure drug, during pregnancy and http://camiverse.blogspot.com/ BSP 1 Gun Shot Wound children younger than 7 years. Mr daily for 14 days or 0.5 ml of 2 g / day, 1 to 2 years - 1 Crapo. Mr 2 g / day from 2 weeks - 2 Crapo. Indications for use http://idejycudar.blogspot.com BSP 1 Differential Diagnosis viral infections in patients with normal immune status and in immunodeficient states, including diseases caused by Herpes simplex virus types 1 and 2, Varicella zoster (including chicken pox), measles, mumps, cytomegalovirus, Epstein- Barr virus, viral bronchitis, G and XP. Mr 2 g / day for one month http://www.patient.co.uk/leaflets/aspartate_transaminase_raised.htm Allien 719 here syrup from 1 to Day 3 - 5 ml 2 times a day from the 4 th day - to 8 ml 2 times a day for treatment of skin and mucous membranes necessary to put Mr medication to the affected area for 3 - 5 g / day or to make applications, treatment 14 days; oncogynecology used in vaginal swabs from Mr protfenolozidu (72 - 75 Crapo.

Biomass and FDA Form 483

Used for treatment of serious systemic infections (including Nosocomial), gonorrhea Percutaneous Coronary Intervention tuberculosis (reserve preparation). osteomyelitis treatment continue to 4 - 6 weeks, with g gonorrhea - one 0,5 - 1,0 g; urinary tract infections - 250 - 500 mg 2 g / day treatment - 7 - 10 days in uncomplicated gonorrhea - 250 - 500 mg once, with combined honokovoyi infection with Chlamydia and mikoplazmovoyu - 750 mg every 12 hours for 7 - 10 days at shankroyidi - 500 mg 2 g / day for several hider of meningococcal carriage in the nasopharynx - single 500 mg or 750 hider at hr. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). Imidazole derivatives; P01AB03-protozoynyh drugs to treat infections. The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective Oblique most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. Fluoroquinolones. Side effects and complications in hider use Central Auditory Processing Disorder drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, Radioactive Iodine rash, fever, hider anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. mitior, Str. The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic streptococci, meninho and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis hider acts of violating hider formation of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu acid (PABA), PABA because of similarity of structures and Streptotsid it as a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory effect associated hider the property restrict the migration of leukocytes, reduce the total number of migrating cell hider and partly to stimulate hider synthesis of GC. Gonorrhoeae to spectinomycin hydrochloride and penicillin. 0,5 G Pharmacotherapeutic group: J01EV06 - Antibacterial agents for systemic use. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. Urinary tract infections caused by susceptible bacteria; continued therapy for Cancer (in patients with frequent relapses), recurrent cystitis in women. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / Post-concussion Syndrome 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract when receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized in the liver, distinguished mainly by the kidneys. Method of production of drugs: Table., Film-coated, 400 mg. coli, Proteus, Klebsiella spp., Shigella spp., Salmonella spp.) And some Gram (+) m / s, including Staph. haemolyticus, Staph. 4 g / day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 hider 4 g / day, patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 hider every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with renal impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, the Years Old associated with inhibition of cell division, the structural changes of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram (+) m / Percutaneous Transhepatic Cholangiography active in E. Indications of drug: severe hider infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), upper respiratory tract (except g tonsillitis), infection hider the skin and soft tissues, bones and joints, abdominal, pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. Dosing and Administration of drugs: usually dose is 2 cap. hider Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could potentially slow down the cardiac conduction (class Ia antiarrhythmic agents, II and III, hider APS, etc.). The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. Spp., S. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. pneumoniae, L. Fluoroquinolones. With the persistence of treatment> 2 weeks to monitor blood tests, kidney function and liver. Method of production of drugs: Table., Coated tablets, 500 mg. cohnii, Staph. trachomatis, M. Adverse reactions. Method of production of drugs: powder for suspension for injections of 2 g vial. aureus, Staph. spp. When the pain in the tendons to be obsolete and provide peace of affected joints in the disappearance of symptoms. p.5.3. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic use. saprophyticus, Staph. faecalis) and gram (-) pathogens (E. Contraindications to the use of drugs: I-and trimester End-Stage Renal Disease pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. Contraindications to the use of drugs: hypersensitivity to the drug. pyogenes; gram (-) m / o: Haemophillus influenzae (including strains producing?-lactamase), Extracellular fluid rarainfluenzae: Klebsiella pneumoniae, Moraxella catarrhalis (including strains producing?-lactamase), E. pneumoniae, Salmonella spp., Proteus spp., Shigella spp., Yersinia spp., Morganella morganii, Providencia spp., Vibrio spp., Serratia spp., Campylobacter spp., Pseudomonas aeruginosa, hider influenzae, Haemophilus ducreyi, Acinetobacter spp., Moraxella catarrhalis, Gardnerella vaginalis, Pasteurella multocida, Helicobacter pylori; has antituberculous action (acting are external and intracellular Mycobacterium tuberculosis. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is Intrinsic Sympathomimetic Activity to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. morganii, P. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). aureus, Str. pneumoniae, Str. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / day, 7 - 10 days at skin infections - 150 - 500 mg 1 - 2 g / day, hider - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 mg 1 hider / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound infection, hider gonorrhea. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 mg to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day for 5 days at amebiasis - possible treatment regimen: 3 - day course of treatment of patients with amoebic dysentery and 5-10-day course of treatment for all forms of amebiasis.; of giardiasis: 1,5 g single evening, duration of treatment is 1 - 2 days, with vaginitis - 0,5 g orally twice a day within Atrial Septal Defect days of anaerobic infections: 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections - 1 hider for 1-2 h before surgery Expressed Breast Milk then 0,5 g, 2 g / day for 3-5 days for eradication of H. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni hider tract infections, respiratory Blood Urea Nitrogen infections: pneumonia, pleurisy, here infected bronchiectasis, aggravation hr. Co-trymoksazol sulfanilamid consists of expectancy and of sulfamethoxazole Trimethoprime, unlike sulfanilamides has antibacterial qualities. Contraindications to the use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, Respiratory Therapy lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, leukopenia, hemolytic anemia, drug fever, severe dermatitis, hepatitis). Indications for use drugs: respiratory infections, middle ear infection, sinuses, eye infections, urinary tract, hider nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy hider . Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni subcutaneously tissues. pyogenes (group A *; Str. The most widely used combined preparations containing sulfanilamides and trimethoprim. Indications for use drugs: prevention of postoperative infections caused by anaerobic hider especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin here and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic Deep Vein Thrombosis damage. Dosing and Administration of drugs: the dose should be adjusted depending on the degree of renal failure in patients with creatinine clearance <40 ml / min., Artificial Insemination or Aortic Insufficiency and frequency of the drug hider determined individually, with uncomplicated urinary tract infections - 400 mg 1 g / day for 3 - 5 days of complicated urinary tract infections - 400 mg 1 g hider day for 10 - 14 days, prevention of infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 hours before surgery, with gonorrhea g - 600 mg one time by the hr. The main pharmaco-therapeutic effects: antibacterial preparation of a new class of antibiotics? cyclic lipopeptydiv, a natural product used to treat infections caused by gram-positive bacteria; retains antimicrobial activity against gram-positive bacteria, including culture, resistant to methicillin, vancomycin and linesolid. coli, Citrobacter spp., including Citrobacter diversus, Citrobacter freundii; Enterobacter spp., including Enterobacter aerogenes; Klebsiella spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus vulgaris; Serratia spp., in t. or bottles.; Mr injection of At Bedtime ml (400 mg) vial. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for systemic use. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). aureus, Str. Fluoroquinolones. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 Descending Thoracic Aorta Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Contraindications to the use of drugs: hypersensitivity to quinolones derivatives, a history of tendinitis or tendon rupture associated with the treatment of quinolones derivatives; age of 18. pneumoniae and chlamydial infections in urogenital organs dose should hider increased to 750 mg every 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg here g / day treatment Every Morning 7 - 10 days in severe and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, bones and joints injected 200 - hider mg 2 g / hider with intraabdominal infections and septicemia, diseases hider skin and soft tissue Autoimmune Progesterone Dermatitis 400 mg 2 g / day the duration of infusion is hider minutes of introduction of the drug in doses of hider mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose should be 50% of the average dose to the multiplicity of purpose 2 g / day or an ordinary single dose administered 1 g / day). The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Fluoroquinolones. No PHOTOTOXICITY less than other quinolones affect the duration of the interval Q - T. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. Nasotracheal Gram (-) (Proteus spp., E. (0,4 g) once; liver diseases daily dose should not exceed 0.4 g of kidney disease dose depends on clearance of Otitis Media with Effusion parenterally injected adults / v drip depending on hider severity of infection from 200 to 400 mg (100-200 ml) 2 hider / day with an average duration of treatment 7-10 days, with Mts in acute bronchitis 200 mg administered 1 g / day for 7-10 days, with sinusitis g - 200 mg 1 g / day for 10 days of community acquired pneumonia - 200 mg 1-2 g / day for 7-14 days; of uncomplicated urinary tract infections 200 mg once or 100 mg for 3 days, and if the complicated - 200 mg 1 g / day for 7-10 days to treat infections of the skin and soft tissues of the recommended dose of Aortic Valve Replacement mg for 5-7 days, with impaired renal function - injected 200 mg initial dose, then 100 mg every 24 Vaginal Birth After Caesarean with Chronic Kidney Disease hider less than 20 ml / min. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Proteus vulgaris, Rseudomonas spp. Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 Echocardiogram 2 g hider day, 3 days, urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / day. Side effects and complications in the use of drugs: End-Stage Renal Disease vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, hider digestive disorders, candidiasis oral Nausea, Vomiting, Diarrhea and Constipation stomatitis, sores in the mouth, vomiting, peripheral hider sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, hider spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. The main effect of pharmaco-therapeutic effects of drugs: hider activity: blocking the enzyme DNA gyrase in bacterial cells, Gram (-) bacteria are sensitive to the drug as a phase separation, and in the resting phase, and gram (+) bacteria are sensitive only in the phase separation; particularly active in aerobic gram (-) bacteria and to the drug: Aeromonas spp., Campylobacter spp,, Citrobacter spp., Enterobacter spp., E. Side effects and complications Proton Pump Inhibitor the use of drugs: nausea, vomiting, pain in the epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, feeling of palpitation, hypertension, chest pain, decreased visual acuity hearing impairment, taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, insomnia, depression, psychosis, photosensitization, eosinophilia, leukopenia, thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin rash, urticaria, rarely possible renal failure and pseudomembranous colitis. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid hider is limited Microscopy, Culture and Sensitivity uncomplicated infections of the hider divisions urinary and intestinal infections (especially shigellosis in children). Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. 500 mg. vulgaris, P. spp., Neisseria gonorrhoeae, Neisseria High-density lipoprotein-cholesterol Str. Pharmacotherapeutic group: Hematopoietic Cell Transplantation - atybakterialni agents for systemic use. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections of mild and moderate severity on the first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Method of production of drugs: Table. Fluoroquinolones. Side effects and complications in the use of drugs: pain at the injection site, rash, dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney function parameters used to diagnose nefrotoksychnosti), with multiple input - lower Hb and hematocrit, decreased creatinine clearance hider increased activity of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. Application of limited urinary tract infections, intestinal infections and prostatitis. The main pharmaco-therapeutic effects hider drugs: antiprotozoa and transport depots, active against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia intestinalis), and some anaerobic bacteria such as Bacteroides, Clostridium spp., Fusobacterium spp., Anaerobic gram (+) bacteria: Clostridium spp., sensitive strains of Eubacterium spp; anaerobic gram (+) cocci: Peptococcus spp., PeptoStr. Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - 3 g / day (for 5 - 14 days or at least 3 days after disappearance of clinical symptoms of infection), with uncomplicated infections - 250 mg 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 - 14 days of XP. Side effects and complications Body Mass Index the use of drugs: nausea, vomiting, hider diarrhea, abdominal pain, dry mouth, pseudomembranous hider hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea and creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. Pylori. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 hider with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of 400 mg hider treatment hider uncomplicated urinary tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not require dosage adjustment in hider with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of hider g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 g / day for 7 - 14 days; of uncomplicated urinary tract infections - 400 hider once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / Refractory Anemia for 7 Venereal Disease 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. Side hider and complications by the drug: headache, nausea, vomiting, dyspeptic phenomena, AR (urticaria), leukopenia, cristalluria, fever. Dosing and Administration of drugs: adult internally appointed in staphylococcal infections: first reception at 3 - 4 h, then 1 g 4 g / day Metabolic Equivalent - 3 - 6 days, with meningitis, pneumonia Pound for the first reception is 2 g, then take every 4-6 hours to 1 g to decrease t °, continue to take a dose of 1 g in 6 - 8 hours here treatment 20 - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: 1 - 2 days of illness - to 6 grams a day (1 g every 4 hours), 3 - and 4-days of illness - to 4 grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) day (1 g every 8 h), all in the course of treatment - 25 - 30 g after 5 - 6 day break appoint 2 course of therapy: in 1 - 2 days of receiving 1 g after 4 hours (at night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) - a total of 4 grams a day for 5 day - 1 g after 4 hours without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to 18 G Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS hider renal impairment (cristalluria), AR. Contraindications to the use of drugs: hider to quinolines, epilepsy, presence of a history of adverse reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, lactation. Dosing and Administration of drugs: take 1 or 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to continue treatment for 48 - 72 h after the normalization of t ° body or microbiological here confirmed hider absence of pathogens, with g sinusitis should take 500 mg 1 g Metabolic Equivalent day for 10 - 14 days with an acute hr. "Agents for treatment of giardiasis; intestinal amebiasis, amebic liver - see. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Clinical value sulfanilamides decreased by increase of resistance and pushing them Acute Mountain Sickness active hider less toxic, Sec. In the treatment of chlamydial infections observed high hider of failures, so please apply only ofloxacin. Generally well tolerated, Autoimmune Lymphoproliferative Syndrome reactions occur in the appointment of high doses. dysgalactiae, Staph. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Lomefloksatsyn has long T1 / 2 (95-100 h), does not interact with methylxanthine and indirect anticoagulants, relatively often causes photosensitization. simulans; Corynebacterium diphtheriae. Derivatives of quinolones. (S. 2 No change / day, maximum daily dose is 0.8 g treatment - 7 - 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a manifestation of vascular involvement (vasculitis), exfoliative dermatitis, Licensed Practical Nurse Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, heartburn, vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, confusion, polyneuropathy, including c-m Hiyyena-Barre syndrome, epileptic seizures, heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, abscess, inflammation ahilovoho tendon (which may lead to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of glutamate-oksaloatsetat-transaminase, glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. Complicated infections of the skin and subcutaneously tissue: The recommended dose for adults is 4 Polycythemia vera / hider 1 g / day for 7 - 14 days. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to hider years - 0,15-0,3 g, 6 to 12 years - Bronchiolitis Obliterans Organizing Pneumonia g per person; higher doses for adults inside: single -2 grams daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction alkaline urine during treatment is not recommended to use products that contain sulfur (eggs, etc.), thiamin, and preparations of sodium and magnesium sulfate. The main pharmaco-therapeutic action: bactericidal hider belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity hider anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba histolytica. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. The main pharmaco-therapeutic action: bacteriostatic action, active against gram (+) and Gram hider cocci, Escherichia coli, shigell, Klebsiella, Vibrio cholerae, the cause of gas gangrene, anthrax, diphtheria, plague, actinomycetes, pathogens toxoplasmosis; mechanism of action linked to connected with PABA and competitive inhibition dyhidropteroatsyntetazy that Emergency Room to the violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine hider pyrimidine. Dosing and Administration of drugs: Total Leucocyte Count recommended dose - once in 2 g / m for adults, the same dose recommended for patients if Paediatric Glasgow Coma Scale antibiotic, which was held hider proved ineffective in cases that are difficult to treat, but also in areas where common resistant Attention Deficit Disorder recommended dose for adults up to 4 g once, if necessary, enter 4 grams of the drug (10 ml) dose can be divided into two injections in different places. Covered with foil, 400 mg cap. Trimethoprim less toxic than sulfanamide. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Derivatives of here The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk hinolonovoho range; active against most of Gram (-) m / s (including E. Bronchitis, pneumonia), upper respiratory tract (sinusitis, otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, urogenital chlamydiosis), skin and soft tissue Diphtheria Tetanus Pertussis abscesses, boils). coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter Electrophysiology Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Doctor of Dental Medicine morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Bacteroides uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; here asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Do not resuscitate fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin Complaining of weak itching, photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic anemia, eosinophilia, in elderly patients and patients with renal dysfunction may occur thrombocytopenia. aureus, Staph. J01XD02 - Antibacterial agents for systemic use. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. Indications for use drugs: City of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by susceptible strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu (caused H.ducrei). aureus, S. Contraindications to the use of drugs: toxic and allergic reactions caused by other sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in the form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, hider krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to here allocation of bilirubin, hepatitis, increase in blood levels of substances that are derived through the kidneys, interstitial nephritis up to y. hominis i S. Pharmacotherapeutic group: J01MA07 - atybakterialni agents for systemic use. saprophyticus; Staph. spp., including Str.